glp-1 patch news 2025 Pipeline Update: August - Prime Therapeutics GLP-1 Pipeline Update: November 2025

In general, discussion will cover inpatient and outpatient problems, with an emphasis on including primary radiographic data, clinical laboratory results and pathology specimens for review

For others, its more elusive a distortion, where once-loved scents now feel off, unfamiliar, or oddly intense

The body gradually adapts, and for most people, the severity decreases over time even as the dose increases

While UTIs commonly cause microscopic or visible blood in urine, other conditions need to be ruled out

doi: 10.2146/ajhp050459 [DOI] [PubMed] [Google Scholar] 48

Cardiovascular protective properties of GLP-1 receptor agonists: more than just diabetic and weight loss drugs